Yakira Capital Management »

Psyence Biomedical shares owned by Yakira Capital Management

Quarter-by-quarter ownership of Psyence Biomedical shares owned by Yakira Capital Management from 13F filings

Historical chart of Yakira Capital Management investment in Psyence Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Psyence Biomedical held by Yakira Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Psyence Biomedical by Yakira Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.4k 77k 0.07

More positions owned by Yakira Capital Management

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Pioneer Natural Resources (PXD)
Iac Com New (IAC)
Virtus Global Divid Income F (ZTR)
Seritage Growth Pptys Cl A (SRG)
American Equity Investment Life Holding (AEL)
Capri Holdings SHS (CPRI)
Monterey Cap Acquisition Cor Class A Com (MCAC)
Axonics Modulation Technolog (AXNX)
Broad Capital Acquisition (BRAC)
Sp Plus (SP)
Fortune Rise Acquisition Cor Cl A (FRLA)
Alpha Star Acquisition Corp Ordinary Shares (ALSA)
United States Steel Corporation (X)
Enerplus Corp (ERF)

View all positions for Yakira Capital Management

Top funds holding Psyence Biomedical

Polar Securities
MMCAP International Inc. SPC
Calamos Advisors
Cantor Fitzgerald, L. P.
Saba Capital Management
Aristeia Capital
Context Capital Management
LMR Partners
Walleye Trading Advisors
Clear Street
D. E. Shaw & Co
Shaolin Capital Management
Tenor Capital Management
Wolverine Asset Management
Cowen And Company

View all funds holding Psyence Biomedical